Lastest Insider Transactions Of DiaMedica Therapeutics Inc. ( DMAC )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
DMACDiaMedica Therapeutics Inc.Wambeke David J.Chief Business Officer2023-11-16Buy20,0002.4649,2002023-11-16 16:37:28
DMACDiaMedica Therapeutics Inc.Von Koch Thomas 10% Owner2023-06-23Buy1,470,5883.404,999,9992023-06-27 16:11:02
DMACDiaMedica Therapeutics Inc.Giuffre Randall MichaelDirectior2023-06-23Buy65,0003.91254,1502023-06-26 16:42:45
DMACDiaMedica Therapeutics Inc.Pauls Dietrich JohnPresident and CEO2023-06-23Buy12,7873.9149,9972023-06-26 16:34:35
DMACDiaMedica Therapeutics Inc.Semba Charles PaulingDirectior2023-06-23Buy12,7873.9149,9972023-06-26 16:26:41
DMACDiaMedica Therapeutics Inc.Kellen ScottCFO and Secretary2023-06-23Buy10,0003.9139,1002023-06-26 16:21:11
DMACDiaMedica Therapeutics Inc.Wambeke David J.Chief Business Officer2023-06-23Buy38,3643.91150,0032023-06-26 16:14:23
DMACDiaMedica Therapeutics Inc.Pilnik Richard D.Directior2023-06-23Buy38,3633.91149,9992023-06-26 16:03:48
DMACDiaMedica Therapeutics Inc.Wambeke David J.Chief Business Officer2023-04-10Buy468,7501.60750,0002023-04-11 17:40:11
DMACDiaMedica Therapeutics Inc.Giuffre Randall MichaelDirectior2022-12-08Buy57,0791.4281,0232022-12-12 16:34:02
DMACDiaMedica Therapeutics Inc.Giuffre Randall MichaelDirectior2022-12-06Buy24,8741.4034,7092022-12-08 16:55:07